-
If you have been charged with an HIV-related crime or civil action – or you represent someone in such action, contact OMSJ immediately. (more…)
-
The word is chutzpa – and it’s hard to imagine a better way to describe UC Berkeley (UCB) Vice Provost Sheldon Zedeck’s assignment of Arthur Reingold to investigate misconduct allegations against Professor Peter Duesberg, PhD. The charges stem from Duesberg’s (et al) report that was published in 2009 by Medical Hypotheses. Citing 35 references that includes South Africa’s (SA) own mortality reports, Prof. Duesberg’s team concluded that: (more…)
-
Johnson Tagarisa grew up during the 1970s when his cousins, brothers and uncles worked in the mines of South Africa. Upon return to their native Zimbabwe, they spoke often of their experiences. By the time that people were starting to “die from AIDS in South Africa,” Johnson was old enough and educated enough to connect the dots. Even when his stepbrother died in 1993, Johnson argued with the doctor that he had died of syphilis because he had (more…)
-
In 2009, Anesthesiology News reported that a 2008 audit at Baystate Medical Center uncovered “one of the largest research frauds in history” committed by anesthesiologist Scott (more…)
-
9 Aug – The US economy has lost 7.8 million jobs since the start of this recession, and jobs are not coming back. Obamacare will lead to the loss of millions of healthcare jobs before the end of the decade. (more…)
-
6 Aug – We spend more than £250 m a year on antidepressants in the UK – and it’s a complete waste of money. They are not much better than sugar pills, they have nasty side – effects, such as sexual dysfunction, and they increase young people’s risk of suicide. New research shows they don’t even work on the brain in the way we thought they did. (more…)
-
Since 2006, Mexican cartels have killed 28,000 men, women and children in drug-related violence. As troubling as these numbers are, those deaths and injuries represent a fraction of those who are negligently killed or injured by US doctors and drug companies every year. Based upon admissions information, 3,607,000 patients suffered adverse drug reactions in 1994 alone. (more…)
-
4 Aug - Months ago, Lord Christopher Monckton put forth his Instrument of Repudiation, CFACT gained thousands of signatures on our own petition against Cap and Trade, and ClimateGate launched a wake up call to America. Now this. Recently, Marc Morano, senior editor of CFACT’s Climate Depot, sat down with Dr. Denis Rancourt to discuss his (more…)
|
-
If you have been charged with an HIV-related crime or civil action – or you represent someone in such action, contact OMSJ immediately. (more…)
-
The word is chutzpa – and it’s hard to imagine a better way to describe UC Berkeley (UCB) Vice Provost Sheldon Zedeck’s assignment of Arthur Reingold to investigate misconduct allegations against Professor Peter Duesberg, PhD. The charges stem from Duesberg’s (et al) report that was published in 2009 by Medical Hypotheses. Citing 35 references that includes South Africa’s (SA) own mortality reports, Prof. Duesberg’s team concluded that: (more…)
-
Johnson Tagarisa grew up during the 1970s when his cousins, brothers and uncles worked in the mines of South Africa. Upon return to their native Zimbabwe, they spoke often of their experiences. By the time that people were starting to “die from AIDS in South Africa,” Johnson was old enough and educated enough to connect the dots. Even when his stepbrother died in 1993, Johnson argued with the doctor that he had died of syphilis because he had (more…)
-
26 July: Ana Cantu was a human guinea pig in a drug trial for $4,800: “The study started out with 20 subjects… For about a week there were 14 subjects. Then they started dropping… Now, we’re down to 7.” (more…)
-
25 July | NY Times Editorial – The flameout of an enormously expensive drug to treat advanced breast cancer will pose a critical test for the Food and Drug Administration. Will the agency have the courage to reverse course when a medical treatment that it approved based on preliminary evidence flops badly in follow-up studies? (more…)
-
Under ObamaCare, the federal government will inevitably decide what kinds of care will get funding and who will get it. Comparative clinical effectiveness research is now a reality as a part of the U.S. government reform of the health care system. As a Canadian Physician, I know this research leads to only one thing – rationing. (more…)
-
Marco Ruggerio MD PhD is a Professor of Molecular Biology and Clinical Radiologist at the University of Firenze, Italy (CV). His RTV interview is posted here: (more…)
-
Dr. Koehnlein was a specialist in internal medicine in the Dept. of Oncology, Univ. of Kiel, Germany between 1983 -1993. Since 1993, he has been in private practice, increasingly treating HIV- positive people who decline antiviral drugs. (more…)
|